ABSTRACT
Genome-wide association studies (GWAS) in admixed populations such as African American (AA) have limited sample sizes, resulting poor performance of polygenic risk scores (PRS). Based on the observations that many disease-causing genes are shared between AA and European ancestry (EA) populations, and some disease-causing variants are located within boundaries of these genes, we proposed a novel gene-based PRS method (PRSgene) by using variants located in these shared disease-causing genes. Using AA GWAS of alcohol use disorder (AUD) from the Million Veteran Program and EA GWAS of problematic alcohol use as the discovery datasets, we identified 858 variants from 410 genes that were AUD-related in both AA and EA. PRSgene calculated using these variants were significantly associated with AUD in three AA cohorts (P-values: 7.61E-05-6.27E-03; Betas: 0.15-0.21) and outperformed PRS calculated using all variants (P-values: 7.28E-03-0.16; Betas: 0.06-0.18). PRSgene was also associated with AUD in an EA cohort (P-value=0.02, Beta=0.11). In AA, individuals in the highest PRSgene decile had an Odds Ratio of 1.76 (95% CI: 1.32-2.34) to develop AUD compared to those in the lowest decile. The 410 genes were enriched in 54 Gene Ontology biological processes, including ethanol oxidation and processes involving synaptic system, which are known to be AUD-related. Additionally, 26 genes were targets of drugs to treat AUD or other diseases, but may be repurposed to treat AUD. Our study demonstrated that our gene-based PRS had improved performance in evaluating AUD risk in AA and provided new insight into identification of AUD genes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
U10AA008401 UL1TR002529 K02DA032573 R01DA054869
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional review board of Indiana University
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors